Document Detail

Fluconazole in the treatment of persistent coccidioidomycosis.
MedLine Citation:
PMID:  2306969     Owner:  NLM     Status:  MEDLINE    
Fluconazole is one of the new antifungal triazoles undergoing clinical trials. We used fluconazole at a dose of 50 or 100 mg/day in an open trial for the treatment of patients with persistent coccidioidomycosis. Fourteen patients were enrolled and treated for a mean of 13 +/- 7 months. Two failed to respond. Of the 12 who responded, one reactivated while being treated, and one died of myocardial infarction after successful treatment of his fungal infection; six had relapses from nine days to 15 months after treatment was stopped. Only four patients are asymptomatic at a mean of 14 +/- 3 months after cessation of treatment. Fluconazole is well tolerated at this dose. In view of its low toxicity, the partial clinical efficacy observed, and the high recurrence rate of chronic coccidioidal infection, it would be justified to try higher doses.
A Catanzaro; J Fierer; P J Friedman
Related Documents :
1653679 - Itraconazole in the treatment of coccidioidomycosis.
6360739 - Tromantadine hydrochloride in the treatment of herpes simplex. results of a double-blin...
10837169 - Combination treatment with famciclovir and a topical corticosteroid gel versus famciclo...
18812049 - Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, west coas...
8508689 - Efficacy of prophylactic and early fluconazole treatment on systemic candidiasis in exp...
1988829 - A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus...
3885669 - Chlamydia, mycoplasmas, ureaplasmas, and yeasts in the lower genital tract of females. ...
12384629 - Drug-eluting stents: clinical experiences and perspectives.
7798429 - Nodulocystic acne: oral gugulipid versus tetracycline.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Chest     Volume:  97     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  1990 Mar 
Date Detail:
Created Date:  1990-04-02     Completed Date:  1990-04-02     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  666-9     Citation Subset:  AIM; IM    
Department of Pulmonary and Critical Care Medicine, University of California, San Diego Medical Center.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Coccidioidomycosis / drug therapy*,  pathology,  radiography
Dermatomycoses / drug therapy,  pathology
Fluconazole / administration & dosage,  therapeutic use*
Lung Diseases, Fungal / drug therapy*,  pathology,  radiography
Middle Aged
Time Factors
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of endobronchial radiation therapy on malignant bronchial obstruction.
Next Document:  Physiologic effects and side effects of prostaglandin E1 in the adult respiratory distress syndrome.